Suchergebnisse - "Tartour, Eric"

PubPharm (16)

1

The polarity and specificity of SARS-CoV2-specific T lymphocyte responses determine disease susceptibility

enthalten in: bioRxiv.org | 2024

von Fahrner, J. | Carrier, A. | De Sousa, E. | +52

2

A synthetic delivery vector for mucosal vaccination

enthalten in: bioRxiv.org | 2024

von Billet, A. | Hadjerci, J. | Tran, T. | +19

3

Serum and Salivary IgG and IgA Response After COVID-19 Messenger RNA Vaccination

enthalten in: JAMA network open | 2024

von Gorochov, G. | Ropers, J. | Launay, O. | +32

4

Incidence of COVID-19 mRNA vaccine symptomatic breakthrough infections during Omicron circulation in adults with or without infection prior to vaccination

enthalten in: Infectious diseases now | 2024

von Durier, C. | Ninove, L. | van der Werf, S. | +25

5

A synthetic delivery vector for mucosal vaccination

enthalten in: Biomaterials | 2023

von Billet, A. | Hadjerci, J. | Tran, T. | +19

6

One-month humoral response following two or three doses of messenger RNA coronavirus disease 2019 vaccines as primary vaccination in specific populations in France : first results from the Agence Nationale Recherche contre le Sida (ANRS)0001S COV-POPART cohort

enthalten in: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases | 2023

von Loubet, P. | Wittkop, L. | Ninove, L. | +24

7

Neutralizing antibodies against SARS-CoV-2 variants following mRNA booster vaccination in adults older than 65 years

enthalten in: Scientific reports | 2022

von Durier, C. | Ninove, L. | Lefebvre, M. | +119

8

Immunogenicity and Safety of Beta Adjuvanted Recombinant Booster Vaccine

enthalten in: bioRxiv.org | 2022

von Launay, O. | Cachanado, M. | Nguyen, L. | +29

9

A comparison of Sars-Cov-2 vaccine platforms : the CoviCompare project

enthalten in: Nature medicine | 2022

von Molino, D. | Durier, C. | Radenne, A. | +28

10

The Polarity and Specificity of Antiviral T Lymphocyte Responses Determine Susceptibility to SARS-CoV-2 Infection in Patients with Cancer and Healthy Individuals

enthalten in: Cancer discovery | 2022

von Fahrner, J. | Lahmar, I. | Goubet, A. | +65

CommentIn: Cancer Discov. 2022 Apr 1;12(4):892-894. - PMID 35373282